Trial Profile
Effects of Atorvastatin on Disease Activity and HDL Cholesterol Anti-Inflammatory Properties in Patients With Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2023
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 21 Jun 2012 Actual end date (September 2005) added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2009 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.